UnitedHealth (UNH) Stock Soars 6% Following Blowout Q1 Earnings Report

Table of Contents UnitedHealth Group delivered impressive first-quarter performance, surpassing Wall Street projections for both profits and sales while increasing its annual forecast. These outcomes arrive as the healthcare giant advances its transformation strategy under CEO Stephen Hemsley, who resumed leadership last May. $UNH Q1 EARNINGS • Revenue $111.7B vs Est. $109.2B• EPS $7.23 vs Est. $6.57• Medical Care Ratio: 83.9% FY26 Guidance• EPS $18.25 vs Est. $17.75 Authorized a $2B stock buyback to be completed by the end of Q2 2026. pic.twitter.com/aCgKHcjMbq — Shay Boloor (@StockSavvyShay) April 21, 2026 First-quarter adjusted profits reached $7.23 per share, significantly exceeding the analyst consensus of $6.58. Sales totaled $111.7 billion, beating projections of $109.4 billion. The quarter’s net profit stood at $6.28 billion, translating to $6.90 per share. Shares surged 5.7% to $342 during premarket trading on Tuesday. UnitedHealth Group Incorporated, UNH The company elevated its full-year adjusted EPS projection to more than $18.25, an increase from the $17.75 estimate provided in January. CFO Wayne DeVeydt informed Barron’s that additional revisions would likely await completion of the second quarter. “We’d like to just see a few more months get under our belt,” he explained. UnitedHealthcare sales expanded to $86.3 billion during the quarter, compared to $84.6 billion in the first quarter of 2025. The operating margin reached 6.6%, an uptick from 6.2% in the comparable period. Among the most encouraging indicators in the quarterly report was the medical care ratio — representing the proportion of premium income allocated to medical expenses. This metric declined to 83.9% in Q1 2026 from 84.8% in Q1 2025. This marks a significant improvement following the ratio’s spike to 91.5% in Q4 2025. Management credited the enhancement to disciplined cost controls and positive reserve adjustments. However, rising utilization patterns and increased unit costs continued to partially counterbalance these gains. UnitedHealth has been strategically exiting unprofitable segments, including certain individual ACA marketplace plans and select Medicare Advantage regions. This strategic shift resulted in membership declining from 49.8 million at the close of 2025 to 49.1 million in Q1 2026. Medicare Advantage membership specifically decreased by 965,000 during the quarter. Optum Health, which faced challenges throughout much of 2025, generated $1.3 billion in adjusted operating earnings in Q1. DeVeydt characterized it as a “very good start” relative to the full-year target of exceeding $1.6 billion. “We view this as a multiyear journey,” he noted. UnitedHealth is committing at least $1.5 billion to artificial intelligence initiatives this year. Management indicates these technology investments are instrumental in addressing a $6 billion challenge stemming from previous Medicare reimbursement modifications. DeVeydt emphasized the payback period for AI projects is “very short.” Earlier this month, Medicare administrators announced an average 2.48% payment increase for insurers in the upcoming year. UNH shares had already gained 9% following that announcement. DeVeydt acknowledged the increase “didn’t fully address” prevailing medical cost trends, noting that benefit adjustments would remain necessary in 2026. Morgan Stanley elevated UNH to “top pick” status on April 16, pointing to expectations for a “string of clean quarters” after the more advantageous Medicare rate disclosure. UnitedHealthcare’s employer self-funded operations helped mitigate some membership declines, while the company’s OptumRx pharmacy benefit division also supported overall revenue expansion.